For More Information, please contact:
CoDa Therapeutics Inc.
Bradford Duft, President and CEO ([email protected])
David Pool, CFO ([email protected])
The Ruth Group (on behalf of CoDa Therapeutics in the US)
Sara Pellegrino – Investors (646-536-7002 / [email protected])
Jason Rando – Media (646-536-7025 / [email protected])
Subscribe to our Free Newsletters!
Cholestatic jaundice occurs when the flow of bile (chole) between the liver and small intestine is ...
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...View All